151 related articles for article (PubMed ID: 37214160)
1. Low treatment success rate among previously treated persons with drug-susceptible pulmonary tuberculosis in Kampala, Uganda.
Izudi J; Okello G; Bajunirwe F
J Clin Tuberc Other Mycobact Dis; 2023 Aug; 32():100375. PubMed ID: 37214160
[TBL] [Abstract][Full Text] [Related]
2. Complete sputum smear monitoring among adults with pulmonary tuberculosis in central Uganda: evidence from a retrospective cohort study.
Nsubuga R; Adrawa N; Okoboi S; Komuhangi A; Izudi J
BMC Infect Dis; 2022 Feb; 22(1):191. PubMed ID: 35216577
[TBL] [Abstract][Full Text] [Related]
3. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for multi-drug and rifampicin resistant tuberculosis and treatment outcomes among previously treated persons with tuberculosis in the era of GeneXpert in rural eastern Uganda.
Izudi J; Tamwesigire IK; Bajunirwe F
J Clin Tuberc Other Mycobact Dis; 2020 May; 19():100153. PubMed ID: 32123755
[TBL] [Abstract][Full Text] [Related]
5. HIV infection modifies the relationship between distance to a health facility and treatment success rate for tuberculosis in rural eastern Uganda.
Olupot B; Adrawa N; Bajunirwe F; Izudi J
J Clin Tuberc Other Mycobact Dis; 2021 May; 23():100226. PubMed ID: 33732899
[TBL] [Abstract][Full Text] [Related]
6. Treatment success and mortality among adults with tuberculosis in rural eastern Uganda: a retrospective cohort study.
Izudi J; Tamwesigire IK; Bajunirwe F
BMC Public Health; 2020 Apr; 20(1):501. PubMed ID: 32295549
[TBL] [Abstract][Full Text] [Related]
7. Sputum smear non-conversion among adult persons with bacteriologically confirmed pulmonary tuberculosis in rural eastern Uganda.
Izudi J; Tamwesigire IK; Bajunirwe F
J Clin Tuberc Other Mycobact Dis; 2020 Aug; 20():100168. PubMed ID: 32529053
[TBL] [Abstract][Full Text] [Related]
8. Negative effects of undernutrition on sputum smear conversion and treatment success among retreatment cases in Uganda: A quasi-experimental study.
Izudi J; Bajunirwe F; Cattamanchi A
J Clin Tuberc Other Mycobact Dis; 2024 May; 35():100422. PubMed ID: 38434999
[TBL] [Abstract][Full Text] [Related]
9. A four-year trend in pulmonary bacteriologically confirmed tuberculosis case detection in Kampala-Uganda.
Kirirabwa NS; Kimuli D; Nanziri C; Sama D; Ntudhu S; Okello DA; Byaruhanga R; Lukoye D; Kasozi S
BMC Pulm Med; 2019 May; 19(1):91. PubMed ID: 31077178
[TBL] [Abstract][Full Text] [Related]
10. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771
[TBL] [Abstract][Full Text] [Related]
11. Predictors of tuberculosis treatment success among HIV-TB co-infected patients attending major tuberculosis treatment sites in Abeokuta, Ogun State, Nigeria.
Akanbi K; Ajayi I; Fayemiwo S; Gidado S; Oladimeji A; Nsubuga P
Pan Afr Med J; 2019; 32(Suppl 1):7. PubMed ID: 30984328
[TBL] [Abstract][Full Text] [Related]
12. Does completion of sputum smear monitoring have an effect on treatment success and cure rate among adult tuberculosis patients in rural Eastern Uganda? A propensity score-matched analysis.
Izudi J; Tamwesigire IK; Bajunirwe F
PLoS One; 2019; 14(12):e0226919. PubMed ID: 31877177
[TBL] [Abstract][Full Text] [Related]
13. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis.
Schwander S; Rüsch-Gerdes S; Mateega A; Lutalo T; Tugume S; Kityo C; Rubaramira R; Mugyenyi P; Okwera A; Mugerwa R
Tuber Lung Dis; 1995 Jun; 76(3):210-8. PubMed ID: 7548903
[TBL] [Abstract][Full Text] [Related]
15. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
16. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
Ambreen A; Jamil M; Rahman MAU; Mustafa T
BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
[TBL] [Abstract][Full Text] [Related]
17. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
Trials; 2020 May; 21(1):383. PubMed ID: 32370774
[TBL] [Abstract][Full Text] [Related]
18. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
Adane K; Spigt M; Dinant GJ
BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
[TBL] [Abstract][Full Text] [Related]
19. Treatment success rate among adult pulmonary tuberculosis patients in sub-Saharan Africa: a systematic review and meta-analysis.
Izudi J; Semakula D; Sennono R; Tamwesigire IK; Bajunirwe F
BMJ Open; 2019 Sep; 9(9):e029400. PubMed ID: 31494610
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
